Transgene S.A. buy metanicnor
Start price
31.05.14
/
50%
€9.91
Target price
18.05.15
€14.00
Performance (%)
-50.20%
End price
18.05.15
€4.94
Summary
This prediction ended on 18.05.15 with a price of €4.94. The BUY prediction by metanicnor for Transgene S.A. performed very badly with a performance of -50.20%. metanicnor has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Transgene S.A. | 14.634% | 14.634% | -30.882% | -57.530% |
| iShares Core DAX® | -0.874% | 5.325% | 6.865% | 65.211% |
| iShares Nasdaq 100 | -0.381% | 1.979% | 25.696% | 90.325% |
| iShares Nikkei 225® | -1.676% | 1.952% | 41.443% | 80.623% |
| iShares S&P 500 | -0.655% | 2.069% | 21.405% | 70.737% |
Comments by metanicnor for this prediction
In the thread Transgene S.A. diskutieren
TG4010
Vielversprechende Ergebnisse einer Studie über TG4010
bald in Phase-III-sein?
Transgen suche einen Finanzpartner
Termin im September 2014 detaillierte Ergebnisse auf TG4010
(Laufzeit überschritten)